NO20091919L - Anvendelse av anti-CD151 antistoff ved behandling av cancer - Google Patents
Anvendelse av anti-CD151 antistoff ved behandling av cancerInfo
- Publication number
- NO20091919L NO20091919L NO20091919A NO20091919A NO20091919L NO 20091919 L NO20091919 L NO 20091919L NO 20091919 A NO20091919 A NO 20091919A NO 20091919 A NO20091919 A NO 20091919A NO 20091919 L NO20091919 L NO 20091919L
- Authority
- NO
- Norway
- Prior art keywords
- antibody
- cancer
- treatment
- protein
- activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Sammendrag Foreliggende oppfinnelse angår anvendelsen av minst et antistoff, eller et funksjonelt fragment derav, som er i stand til å binde til CD151 proteinet og derved inhibere tumorvekst, for fremstilling av et medikament tiltenkt for behandling av cancer. Oppfinnelsen angår også en sammensetning for behandling av cancer, som innbefatter, som aktiv ingrediens, minst et anti-CD151 antistoff, eller et funksjonelt fragment derav, som er i stand til å binde til CD151 proteinet og/eller inhibere utviklingen av primære tumorer og/eller inhibere dets metastasefremmende aktivitet, hvilke antistoffer kan bestå av antistoffene TS151 og/eller TS151r.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609135A FR2907341B1 (fr) | 2006-10-18 | 2006-10-18 | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
PCT/FR2007/001688 WO2008049990A2 (fr) | 2006-10-18 | 2007-10-15 | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091919L true NO20091919L (no) | 2009-05-18 |
Family
ID=37866318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091919A NO20091919L (no) | 2006-10-18 | 2009-05-18 | Anvendelse av anti-CD151 antistoff ved behandling av cancer |
Country Status (28)
Country | Link |
---|---|
US (2) | US8178096B2 (no) |
EP (1) | EP2079482B1 (no) |
JP (2) | JP5757646B2 (no) |
KR (1) | KR101521863B1 (no) |
CN (1) | CN101528256B (no) |
AT (1) | ATE499387T1 (no) |
AU (1) | AU2007310763B2 (no) |
BR (1) | BRPI0717455A2 (no) |
CA (1) | CA2665912C (no) |
DE (1) | DE602007012743D1 (no) |
DK (1) | DK2079482T3 (no) |
ES (1) | ES2361696T3 (no) |
FR (1) | FR2907341B1 (no) |
HK (1) | HK1132904A1 (no) |
HR (1) | HRP20110374T1 (no) |
IL (1) | IL198043A (no) |
MA (1) | MA30777B1 (no) |
MX (1) | MX2009003039A (no) |
NO (1) | NO20091919L (no) |
NZ (1) | NZ575781A (no) |
PL (1) | PL2079482T3 (no) |
PT (1) | PT2079482E (no) |
RS (1) | RS51729B (no) |
RU (1) | RU2464041C2 (no) |
SI (1) | SI2079482T1 (no) |
TN (1) | TN2009000144A1 (no) |
UA (1) | UA99601C2 (no) |
WO (1) | WO2008049990A2 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873699B1 (fr) | 2004-07-29 | 2009-08-21 | Pierre Fabre Medicament Sa | Nouveaux anticorps anti igf ir rt leurs utilisations |
FR2907341B1 (fr) * | 2006-10-18 | 2012-08-17 | Pf Medicament | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
FR2929946B1 (fr) * | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
EP2308897A1 (en) * | 2009-10-09 | 2011-04-13 | Pierre Fabre Medicament | Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer |
EP2371863A1 (en) * | 2010-03-30 | 2011-10-05 | Pierre Fabre Médicament | Humanized anti CXCR4 antibodies for the treatment of cancer |
WO2012131680A2 (en) | 2011-03-28 | 2012-10-04 | Yeda Research And Development Co. Ltd. | Compositions and methods for treating inflammation |
CN102605057A (zh) * | 2012-02-28 | 2012-07-25 | 芮屈生物技术(上海)有限公司 | 癌症病变前期CD151的mRNA水平原位杂交检测试剂盒及检测方法和应用 |
US9982057B2 (en) | 2014-11-17 | 2018-05-29 | Pelican Therapeutics, Inc. | Human TNFRSF25 antibody |
CN109219620B (zh) | 2016-06-09 | 2023-01-31 | 派立卡恩治疗公司 | 抗-tnfrsf25抗体 |
CN108690136B (zh) * | 2017-04-05 | 2022-09-20 | 凯惠科技发展(上海)有限公司 | 一种人源化抗tpbg抗体及其制备方法、其偶联物和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
WO1999066027A1 (en) * | 1998-06-15 | 1999-12-23 | The Research Foundation Of State University Of New York | Monoclonal antibodies that recognize antigens associated with tumor metastasis |
JP2003189851A (ja) * | 2001-12-28 | 2003-07-08 | Japan Science & Technology Corp | 抗ヒトcd151モノクローナル抗体産生ハイブリドーマ |
JP2003321494A (ja) | 2002-02-26 | 2003-11-11 | Daiichi Fine Chemical Co Ltd | プロmmp−7の活性化調節方法 |
EP2041175A4 (en) * | 2006-06-23 | 2011-03-16 | Augmenta Biolog Llc | TARGETED IMMUNOJUGATE |
FR2907341B1 (fr) * | 2006-10-18 | 2012-08-17 | Pf Medicament | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
FR2929946B1 (fr) * | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
-
2006
- 2006-10-18 FR FR0609135A patent/FR2907341B1/fr not_active Expired - Fee Related
-
2007
- 2007-10-15 DE DE602007012743T patent/DE602007012743D1/de active Active
- 2007-10-15 CN CN2007800389060A patent/CN101528256B/zh not_active Expired - Fee Related
- 2007-10-15 UA UAA200904808A patent/UA99601C2/ru unknown
- 2007-10-15 US US12/311,682 patent/US8178096B2/en not_active Expired - Fee Related
- 2007-10-15 WO PCT/FR2007/001688 patent/WO2008049990A2/fr active Application Filing
- 2007-10-15 KR KR1020097010125A patent/KR101521863B1/ko active IP Right Grant
- 2007-10-15 SI SI200730592T patent/SI2079482T1/sl unknown
- 2007-10-15 BR BRPI0717455-1A2A patent/BRPI0717455A2/pt active Search and Examination
- 2007-10-15 DK DK07858450.5T patent/DK2079482T3/da active
- 2007-10-15 AT AT07858450T patent/ATE499387T1/de active
- 2007-10-15 RS RS20110202A patent/RS51729B/en unknown
- 2007-10-15 RU RU2009118440/15A patent/RU2464041C2/ru not_active IP Right Cessation
- 2007-10-15 JP JP2009532841A patent/JP5757646B2/ja not_active Expired - Fee Related
- 2007-10-15 PT PT07858450T patent/PT2079482E/pt unknown
- 2007-10-15 MX MX2009003039A patent/MX2009003039A/es active IP Right Grant
- 2007-10-15 EP EP07858450A patent/EP2079482B1/fr active Active
- 2007-10-15 NZ NZ575781A patent/NZ575781A/en not_active IP Right Cessation
- 2007-10-15 CA CA2665912A patent/CA2665912C/fr not_active Expired - Fee Related
- 2007-10-15 PL PL07858450T patent/PL2079482T3/pl unknown
- 2007-10-15 ES ES07858450T patent/ES2361696T3/es active Active
- 2007-10-15 AU AU2007310763A patent/AU2007310763B2/en not_active Ceased
-
2009
- 2009-04-03 MA MA31758A patent/MA30777B1/fr unknown
- 2009-04-06 IL IL198043A patent/IL198043A/en active IP Right Grant
- 2009-04-17 TN TNP2009000144A patent/TN2009000144A1/fr unknown
- 2009-05-18 NO NO20091919A patent/NO20091919L/no not_active Application Discontinuation
- 2009-11-10 HK HK09110445.1A patent/HK1132904A1/xx not_active IP Right Cessation
-
2011
- 2011-05-19 HR HR20110374T patent/HRP20110374T1/hr unknown
-
2012
- 2012-04-16 US US13/447,626 patent/US20120219569A1/en not_active Abandoned
-
2013
- 2013-07-09 JP JP2013143422A patent/JP5723420B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091919L (no) | Anvendelse av anti-CD151 antistoff ved behandling av cancer | |
WO2010019702A3 (en) | Ddr1-binding agents and methods of use thereof | |
EA200970317A1 (ru) | Комбинированное лечение опухолей, экспрессирующих cd38 | |
WO2014012007A3 (en) | Rspo3 binding agents and uses thereof | |
MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
UA108193C2 (uk) | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
MX2009005597A (es) | Miembros de enlace para interleucina 6. | |
NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
MX349198B (es) | Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos. | |
NO20085422L (no) | Bindingsproteiner for hepatocyttvekstfaktor (HGF) | |
NO20085421L (no) | Bindingsproteiner for hepatocyttvekstfaktor (HGF) | |
BRPI0606891A2 (pt) | anticorpos dr5 e usos dos mesmos | |
EA201070636A1 (ru) | Ингибирование рецептора белка, стимулирующего макрофаги (ron), и способы его лечения | |
WO2005090406A3 (en) | Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth | |
UA99602C2 (ru) | Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток | |
EP2175879A4 (en) | TREATMENT OF DISEASES ASSOCIATED WITH PRION PROTEIN | |
EA200801425A1 (ru) | Диазепиноны | |
NZ589795A (en) | Use of LM-1 antibody which binds to NONO/nmt55 protein to prevent metastasis | |
WO2008032324A3 (en) | Combination therapy for tumoral disease treatment | |
DE602007009204D1 (de) | Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung | |
DE602005025459D1 (de) | Ephb4-bindende antikörper zur inhibierung von angiogenese und tumorwachstum | |
EA202090198A1 (ru) | Комбинированное лечение опухолей, экспрессирующих cd38 | |
UA98756C2 (ru) | Антитело, которое связывается с cd38, для лечения заболевания, опосредованного cd38 | |
UA107655C2 (uk) | Селективні інгібітори антиапоптичних білків bcl-2 для лікування раку і імунних захворювань | |
FR2929519B1 (fr) | Utilisation d'un anticorps anti-cd151 pour le traitement precoce des cancers. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |